Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
15.1M
-
Shares change
-
+443K
-
Total reported value, excl. options
-
$58.5M
-
Value change
-
+$1.49M
-
Put/Call ratio
-
8.42
-
Number of buys
-
28
-
Number of sells
-
-27
-
Price
-
$3.89
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2023
77 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q3 2023.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.1M shares
of 92.4M outstanding shares and own 16.28% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.04M shares), Avoro Capital Advisors LLC (2.95M shares), FMR LLC (1.5M shares), VANGUARD GROUP INC (1.23M shares), BlackRock Inc. (1.05M shares), GEODE CAPITAL MANAGEMENT, LLC (417K shares), STATE STREET CORP (383K shares), Caligan Partners LP (260K shares), NORTHERN TRUST CORP (187K shares), and Boxer Capital, LLC (167K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.